Leukotriene B4 at low dosage negates the catabolic effect of prostaglandin E2 in human patellar tendon fibroblasts
- 20 February 2006
- Vol. 372, 103-109
- https://doi.org/10.1016/j.gene.2005.12.013
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Chronic tendon pathology: molecular basis and therapeutic implicationsExpert Reviews in Molecular Medicine, 2005
- Cyclic Mechanical Stretching of Human Tendon Fibroblasts Increases the Production of Prostaglandin E 2 and Levels of Cyclooxygenase Expression: A Novel In Vitro Model StudyConnective Tissue Research, 2003
- Metabolism and inflammatory mediators in the peritendinous space measured by microdialysis during intermittent isometric exercise in humansThe Journal of Physiology, 1999
- Molecular mechanisms of diverse actions of prostanoid receptorsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- An In Vitro Investigation Into the Effects of Repetitive Motion and Nonsteroidal Antiinflammatory Medication on Human Tendon FibroblastsThe American Journal of Sports Medicine, 1995
- Role of Matrix Metalloproteinases in Human Periodontal Diseases*The Journal of Periodontology, 1993
- Role of Matrix Metalloproteinases in Human Periodontal DiseasesThe Journal of Periodontology, 1993
- Leukotriene B4 transcriptionally activates interleukin‐6 expression involving NK‐xB and NF‐IL6European Journal of Immunology, 1992
- Binding of leukotriene C4 to rat lung fibroblasts and stimulation of collagen synthesis in vitroBiochemistry, 1988
- PGE2 causes a coordinate decrease in the steady state levels of fibronectin and types I and III procollagen mRNAs in normal human dermal fibroblastsBiochemical and Biophysical Research Communications, 1987